Purchase Order 75N95022P00731
- Not listed
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $103,000.00 firm-fixed-price purchase order to ChemDiv, Inc. to provide a compound library of 8,000 specific and unique small molecule compounds. The compounds are being procured for the National Center for Advancing Translational Sciences (NCATS) to support their Genesis screening library. The contract does not have a set-aside designation, and the place of performance is San...
- The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) awarded a $30,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey for the synthesis of synthetic compounds to support NCATS. Under the terms of the award, Medchemexpress will provide synthetic compound synthesis services to NCATS by November 11, 2022. No set-aside provisions were applied to this procurement. As the lead institute for NIH's translational...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...
- This is a $235,092.20 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to MedChemExpress LLC, a New Jersey-based provider of biochemicals and other life science research materials. The contract is for the delivery of a custom chemical library of 84 items to the National Center for Advancing Translational Sciences (NCATS) to support its COVID-19 research. No set-aside designation was used. As a...
- Medchemexpress LLC has been awarded a firm fixed price purchase order valued at $24,700 by the National Institutes of Health's National Center for Advancing Translational Sciences to provide 29 compounds in support of the agency's Tox21 research project examining the NS3-NS2B complex. As part of its mission to translate scientific discoveries into clinical applications, NCATS utilizes screening programs like Tox21 to evaluate the effects of environmental chemicals on biological pathways...
- The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $240,000.00 firm fixed-price purchase order to Chemogenics Biopharma, LLC, a for-profit limited liability company, for custom synthesis and bioanalytical services to support NCATS' internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases. The 12-month contract is not set aside and is awarded under FAR Part 13 simplified...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), to Life Chemicals USA, Inc. for $50,697.50. The order is for a screening compound set of 3,750 small molecules to be used in the Genesis screening library. The purchase was made through a non-competitive combined synopsis/solicitation process. There was no set-aside designation for this award. The award has a...
- This federal contract award is for the delivery of a small molecules screening library to the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services. The $23,095 firm fixed-price purchase order was awarded to Medchemexpress LLC, a foreign-owned, minority-owned, and self-certified small disadvantaged business based in New Jersey. The contract does not have a set-aside designation. The award is to...
- The National Center for Advancing Translational Sciences, a component of the U.S. Department of Health and Human Services' National Institutes of Health, awarded a $22,226.00 firm fixed price purchase order to MedChemExpress LLC, a New Jersey-based provider of life science research materials. The contract is to obtain 5-milligram samples of biologically active small molecules with well-defined mechanisms of action. This material will be used to create the MIPE 5.1 molecular library, a collection...
- Medchemexpress LLC was awarded a firm fixed price purchase order valued at seventy-seven thousand one hundred ninety-three dollars and forty-one cents ($77,193.41) by the Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse to deliver one chemical library of five hundred nine bioactive compounds. The award originated from a sources sought notice issued by the National Institutes of Health's National Center for Advancing Translational...
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) awarded a $471,850 firm fixed price purchase order to Medkoo Biosciences for a small molecule library. The library will contain 52 specific compounds requested in the solicitation to support NCATS' Early Translation Branch pre-clinical screening and research efforts. The library must be delivered to the NIH location in Bethesda, Maryland within one year of the September 2022 award date. This contract was set aside for total small businesses and will provide the compounds sought in the original solicitation to increase diversity in NCATS' chemical collections and support medicinal chemistry research. Medkoo Biosciences will deliver the small molecule library as the prime contractor to further the work of NCATS' pre-clinical research programs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Small Molecules Library for NCATS ETB Pre-Clinical Library | 75N95022Q00363 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 2/2 | 8/25/22, 6:23 PM | |
Chemical Library | 75N95022Q00363 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Pre-Solicitation 1/2 | 7/1/22, 1:33 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($29k) | 9/18/23 | |
| Not listed | Not listed | $501.0k | 9/21/22 |